[关键词]
[摘要]
泽泻始载于《神农本草经》,列为上品,历代本草中多有收载。泽泻主要分布于福建、四川和江西,具利水渗湿、泄热、化浊调脂之效,现代药理活性广泛,其临床研究也逐步深入。从本草考证、化学成分和药理作用等几个方面对泽泻的研究现状进行综述,在此基础上明确泽泻不同基原的差异,并根据质量标志物(Q-marker)的概念,从生源途径出发,结合药效、新药用途及炮制等的研究,预测泽泻的质量标志物,以期为泽泻有效成分的定性定量分析和新标准的制定提供科学依据。
[Key word]
[Abstract]
Alismatis Rhizoma was first published in the "Shennong's Classic of Materia Medica", listed as top grade, and most of the ancient herbals have been collected. Alismatis Rhizoma is mainly distributed in Fujian, Sichuan, and Jiangxi provinces. Alismatis Rhizoma has the effect of diffusing water and dampness, releasing heat, removing turbidity, and reducing lipid. Its modern pharmacological activity is extensive, and its clinical research is deepening gradually. This paper summarizes the research status of Alismatis Rhizoma from the aspects of herbal textual research, chemical composition, and pharmacological action. On this basis, the differences of different radicals of Alismatis Rhizoma are clarified. Based on the concept of quality marker (Q-marker), the Q-markers of Alismatis Rhizoma are predicted from the point of origin, combined with the research of pharmacodynamics, new medicinal uses and processing, in order to perform qualitative and quantitative analysis of the effective components of Alismatis Rhizoma and provide scientific basis for formulation of new standards.
[中图分类号]
[基金项目]
国家中药标准化项目(ZYBZH-Y-JX-27);国家自然科学基金重点项目(81430096)